Abstract
The physiologic sequelae of Renal Artery Stenosis (RAS) results from narrowing of renal artery lumen which leads to diminished renal perfusion. The consequences of RAS range from asymptomatic to refractory hypertension to ischemic nephropathy eventually leading to end-stage renal disease (ESRD).
Keywords: Renal Artery Stenosis (RAS), hypertension, end-stage renal disease (ESRD), nephropathy, etiology
Current Hypertension Reviews
Title: Renal Artery Stenting: Efficacy and Complications
Volume: 5 Issue: 1
Author(s): Mohsen Bannazadeh and Timur Sarac
Affiliation:
Keywords: Renal Artery Stenosis (RAS), hypertension, end-stage renal disease (ESRD), nephropathy, etiology
Abstract: The physiologic sequelae of Renal Artery Stenosis (RAS) results from narrowing of renal artery lumen which leads to diminished renal perfusion. The consequences of RAS range from asymptomatic to refractory hypertension to ischemic nephropathy eventually leading to end-stage renal disease (ESRD).
Export Options
About this article
Cite this article as:
Bannazadeh Mohsen and Sarac Timur, Renal Artery Stenting: Efficacy and Complications, Current Hypertension Reviews 2009; 5 (1) . https://dx.doi.org/10.2174/157340209787314342
DOI https://dx.doi.org/10.2174/157340209787314342 |
Print ISSN 1573-4021 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6506 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Sesamin and Sesamolin: Natures Therapeutic Lignans
Current Enzyme Inhibition Cardiovascular Health vs Cardiovascular Risk A 2011 Update: Cardiovascular Risk Stratification, the Basis to Reach Therapeutic Goals
Current Hypertension Reviews Platelet Turnover in Atherothrombotic Disease
Current Pharmaceutical Design Evaluation of In Vivo Efficacy of Aqueous Extract of Aerial Parts of Cynodon dactylon in Rats with Simultaneous Type 2 Diabetes and Hypertension
Current Bioactive Compounds Vasoactive Compounds in the Neonatal Period
Current Medicinal Chemistry Barker and Brenner: A Basis for Hypertension?
Current Hypertension Reviews Cerebral Arachidonate Cascade in Dementia: Alzheimers Disease and Vascular Dementia
Current Neuropharmacology A Medical Approach to the Monoamine Oxidase Inhibition by Using 7Hbenzo[ e]perimidin-7-one Derivatives
Current Topics in Medicinal Chemistry Adipose Tissue as a Target of HIV-1 Antiretroviral Drugs. Potential Consequences on Metabolic Regulations
Current Pharmaceutical Design Rottlerin: Bases for a Possible Usage in Psoriasis
Current Drug Metabolism Vasopressin and Oxytocin in Control of the Cardiovascular System
Current Neuropharmacology A Mini Review on the Chemistry and Neuroprotective Effects of Silymarin
Current Drug Targets Biological Signatures of Alzheimer’s Disease
Current Topics in Medicinal Chemistry The Role of microRNAs in the Initiation and Progression of Stable Atheromatous Plaque
Current Pharmaceutical Design Fetal Mechanisms That Lead to Later Hypertension
Current Drug Targets Cardiovascular Morbidity and Mortality in Peripheral Arterial Disease
Current Drug Targets - Cardiovascular & Hematological Disorders Insights into the Relationship Between Hypertension and Albuminuria
Current Hypertension Reviews Cellular Senescence in Cardiovascular Diseases: Potential Age-Related Mechanisms and Implications for Treatment
Current Pharmaceutical Design Coronary Risk Factors in the Elderly: Their Interactions and Treatment
Current Pharmaceutical Design Pharmacogenomic Considerations of the Insertion / Deletion Gene Polymorphism of the Angiotensin I-Converting Enzyme and Coronary Artery Disease
Current Vascular Pharmacology